Peripheral neuropathy: A neglected cause of disability in COPD - A narrative review

Respir Med. 2022 Sep:201:106952. doi: 10.1016/j.rmed.2022.106952. Epub 2022 Aug 11.

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory syndrome with systemic involvement leading to various cardiovascular, metabolic, and neurological comorbidities. It is well known that conditions associated with oxygen deprivation and metabolic disturbance are associated with polyneuropathy, but current data regarding the relationship between COPD and peripheral nervous system pathology is limited. This review summarizes the available data on the association between COPD and polyneuropathy, including possible pathophysiological mechanisms such as the role of hypoxia, proinflammatory state, and smoking in nerve damage; the role of cardiovascular and metabolic comorbidities, as well as the diagnostic methods and screening tools for identifying polyneuropathy. Furthermore, it outlines the available options for managing and preventing polyneuropathy in COPD patients. Overall, current data suggest that optimal screening strategies to diagnose polyneuropathy early should be implemented in COPD patients due to their relatively common association and the additional burden of polyneuropathy on quality of life.

Keywords: COPD; Neuroprotection; Peripheral neuropathy; Screening.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Comorbidity
  • Humans
  • Peripheral Nervous System Diseases* / diagnosis
  • Peripheral Nervous System Diseases* / epidemiology
  • Peripheral Nervous System Diseases* / etiology
  • Polyneuropathies* / complications
  • Polyneuropathies* / epidemiology
  • Pulmonary Disease, Chronic Obstructive* / complications
  • Pulmonary Disease, Chronic Obstructive* / diagnosis
  • Pulmonary Disease, Chronic Obstructive* / epidemiology
  • Quality of Life